Defective Integrator activity shapes the transcriptome of patients with multiple sclerosis
Life Science Alliance · 2024
DOI: 10.26508/lsa.202402586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Yevheniia Porozhan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Biological Adaptation and Ageing, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: Multiple Sclerosis, Transcriptome, Chromobox Protein Homolog 5, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, AU | Sundhedsvidenskabelige Fakultet, Aarhus Universitet, Scleroseforeningen.
Abstract (Originalsprache)
HP1α/CBX5 is an epigenetic regulator with a suspected role in multiple sclerosis (MS). Here, using high-depth RNA sequencing on monocytes, we identified a subset of MS patients with reduced CBX5 expression, correlating with progressive stages of the disease and extensive transcriptomic alterations. Examination of rare non-coding RNA species in these patients revealed impaired maturation/degradation of U snRNAs and enhancer RNAs, indicative of reduced activity of the Integrator, a complex with suspected links to increased MS risk. At protein-coding genes, compromised Integrator activity manifested in reduced pre-mRNA splicing efficiency and altered expression of genes regulated by RNA polymerase II pause–release. Inactivation of Cbx5 in the mouse mirrored most of these transcriptional defects and resulted in hypersensitivity to experimental autoimmune encephalomyelitis. Collectively, our observations suggested a major contribution of the Integrator complex in safeguarding against transcriptional anomalies characteristic of MS, with HP1α/CBX5 emerging as an unexpected regulator of this complex’s activity. These findings bring novel insights into the transcriptional aspects of MS and provide potential new criteria for patient stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Biological Adaptation and Ageing, Sorbonne Université, Paris, France.
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Forum, Aarhus, Denmark.
- Department of Neurology, Hospital of Southern Jutland and Research Unit in Neurology, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.
- Institut de Biologie Paris-Seine (IBPS), CNRS UMR 8256, Biological Adaptation and Ageing, Sorbonne Université, Paris, France christian.muchardt@sorbonne-universite.fr.
ORCID-Profile: Mikkel Carstensen, Sandrine Thouroude, Mickael Costallat, Christophe Rachez, Eric Batsché, Thor Petersen, Tove Christensen, Christian Muchardt
Förderung
- Agence Nationale de la Recherche
- AU | Sundhedsvidenskabelige Fakultet, Aarhus Universitet
- Scleroseforeningen
- Beckett-Fonden
- Dagmar Marshalls Fond
- Knud Højgaards Fond
- Aage og Johanne Louis-Hansens Fond
- Oticon Fonden
Zitieren
APA
Porozhan, Y., Carstensen, M., Thouroude, S., Costallat, M., Rachez, C., Batsché, E., Petersen, T., Christensen, T., & Muchardt, C. (2024). Defective Integrator activity shapes the transcriptome of patients with multiple sclerosis. Life Science Alliance. https://doi.org/10.26508/lsa.202402586
Vancouver
Porozhan Y, Carstensen M, Thouroude S, Costallat M, Rachez C, Batsché E, et al. Defective Integrator activity shapes the transcriptome of patients with multiple sclerosis. Life Science Alliance. 2024. doi:10.26508/lsa.202402586
BibTeX
@article{Porozhan2024,
author = {Porozhan, Yevheniia and Carstensen, Mikkel and Thouroude, Sandrine and Costallat, Mickael and Rachez, Christophe and Batsché, Eric and Petersen, Thor and Christensen, Tove and Muchardt, Christian},
title = {Defective Integrator activity shapes the transcriptome of patients with multiple sclerosis},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202402586}
}
EUVIMED